Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nesiritide in Preclinical Systolic and Diastolic Dysfunction
NCT00387621Phase 2Completed
- Start
- Feb 2006
- Primary completion
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Placebo First with Nesiritide First (2 arms). Primary endpoints: Urinary Sodium Excretion and Urinary cGMP Excretion. Started Feb 2006; status: completed.
02
Drugs
nesiritide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00387621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00387621.